Search

You searched for "Stone"

1225 results found

LUTS among Caucasian-European men who have sex with men: findings from a real-life survey

1 March 2016 | | URO - Endourology & Stones
This study is the first of its kind to report an association between men who have sex with men (MSM) and lower urinary tract symptoms (LUTS). Nine hundred and forty-nine consecutive individuals who presented to a uro-andrology clinic for complaints...

Penile clamp device – a new indication?

1 September 2015 | | URO - Andrology
This study originates from New Zealand and looks at men affected by post-prostatectomy incontinence (PPI). These patients are difficult to manage with the options of further surgery, indwelling catheters or pads. The aim of this questionnaire study (IIQ 7) was...

Health-related quality of life in men with corrected hypospadias

1 March 2014 | | URO - Paediatric Urology
More and more studies on long-term outcomes of paediatric operations are being published, many of which concentrate on health-related quality of life (HRQol) scores. This paper compared 45 men with corrected hypospadias (mean age 26.2 years +/- 5.1 years) with...

The natural history of prostate cancer on MRI

1 September 2019 | | URO - Urologic Oncology, URO - Uroradiology
Multiparametric MRI features heavily on a number of active surveillance protocols. This study looked at 86 men on active surveillance who had an mpMRI prior to 2013 to assess how lesions changed over time. Two blinded radiologists examined all the...
The Journal of Urology cover image.

Refining management of non-visible haematuria

2 March 2022 | | URO - Functional / Reconstructive Urology, URO - Infection, URO - Urologic Oncology
The optimal evaluation of non-visible haematuria (NVH) continues to be debated, with competing interests of avoidance underdiagnosis and the harms of over-testing. Current National Institute for Health & Care Excellent (NICE) guidance recommends referral for patients ≥60 years with NVH....

Recent developments in bladder cancer – NMIBC

3 May 2022 | | URO - Urologic Oncology
Every year, roughly 10,300 individuals are diagnosed with bladder cancer in the UK, making it the 11th most common cancer in the UK, and the eighth most common cancer in men [1]. Of those diagnosed with the disease, 75-85% will...

Trials offering cytoreductive surgery for men with de novo synchronous metastatic prostate cancer

8 November 2021 | | URO - Basic Science Research, URO - Urologic Oncology
Life expectancy in men diagnosed with de novo synchronous metastatic hormone-sensitive prostate cancer (mHSPC) has risen to a median of 4.8 years with upfront systemic agents (such as docetaxel) in addition to standard androgen deprivation therapy (ADT) [1-3]. Within this...

Visual-estimation (cognitive), image-fusion (software) and in-bore targeted prostate biopsy: is there an optimal approach?

3 March 2021 | | URO - Urologic Oncology, URO - Technology
The diagnostic superiority of multiparametric magnetic resonance imaging (mpMRI) prior to targeted and systematic prostate biopsy over systematic transrectal ultrasound-guided (TRUS) biopsy alone in the detection of clinically significant prostate cancer (csPCa) has been proven by multiple level 1 studies...

RSM (Royal Society of Medicine) Complexity and Complications: Navigating Advanced Prostate Cancer

21 November 2025
This year’s RSM Cancer Day will focus on the evolving management of prostate cancer. With emerging evidence supporting radical prostatectomy in oligometastatic disease, the programme will examine patient selection, treatment strategies, and the latest advances for managing advanced-stage cases.

Stereotactic body radiotherapy for oligometastatic disease secondary to urological cancer

1 January 2016 | | URO - Urologic Oncology, URO - Technology
The concept of oligometastatic disease is controversial. The traditional model of cancer, which most of us learnt at medical school, is of a disease which starts confined to an organ, for example the prostate, where it can be cured with...

The multidisciplinary team meeting: London calling!

1 January 2015 | | URO - Technology
The multidisciplinary team meeting, or MDT, is the foundation of cancer management in the UK. The MDT consists of a group of experts in different fields of medicine and surgery coming together at regular intervals to discuss the diagnosis and...

Genital gender affirmation surgery for transgender men

5 May 2021 | | URO - Andrology, URO - Functional / Reconstructive Urology
Genital gender affirmation surgery (GAS) is the final step in the transition journey for transgender men. Genital GAS involves a combination of procedures to surgically align physical characteristics with one’s gender identity. These needs change between each individual depending on...